STOCK TITAN

[144] Twist Bioscience Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

TWST Form 144 summary: This notice reports proposed and recent sales of Twist Bioscience common stock by an individual identified as Patrick Finn. The filer proposes to sell 206 shares via Fidelity Brokerage with an aggregate market value of $6,007.15 and lists the company's outstanding share count as 60,360,925. The 206 shares were acquired on 10/01/2025 through restricted stock vesting and payment is listed as compensation. The filing also discloses four reported sales in the prior three months totaling 7,470 shares for $225,564.62. The signer represents they have no undisclosed material information about the issuer.

Riassunto del modulo TWST 144: Questo avviso riporta la vendita proposta e recente di azioni ordinarie di Twist Bioscience da parte di un individuo identificato come Patrick Finn. Il dichiarante propone di vendere 206 azioni tramite Fidelity Brokerage con un valore di mercato aggregato di $6.007,15 e indica il numero di azioni in circolazione della società come 60.360.925. Le 206 azioni sono state acquisite il 01/10/2025 tramite vesting di azioni limitate e il pagamento è indicato come compenso. La presentazione dichiara inoltre quattro vendite riportate nei tre mesi precedenti per un totale di 7.470 azioni per $225.564,62. Il firmatario dichiara di non possedere informazioni materiali non divulgate sull'emittente.

Resumen del Formulario 144 de TWST: Este aviso informa ventas propuestas y recientes de acciones ordinarias de Twist Bioscience por una persona identificada como Patrick Finn. El presentante propone vender 206 acciones a través de Fidelity Brokerage con un valor de mercado agregado de $6,007.15 y señala el número de acciones en circulación de la empresa como 60,360,925. Las 206 acciones se adquirieron el 01/10/2025 mediante vesting de acciones restringidas y el pago se indica como compensación. La presentación también divulga cuatro ventas reportadas en los tres meses anteriores por un total de 7,470 acciones por $225,564.62. El firmante declara no poseer información material no revelada sobre el emisor.

TWST Form 144 요약: 이 공지는 Patrick Finn으로 식별된 개인이 Twist Bioscience의 보통주를 제안 및 최근에 매각한 내용을 보고합니다. 제출자는 Fidelity Brokerage를 통해 206주를 매도할 계획이며 합산 시장가치 $6,007.15를 제시하고 회사의 발행주식 수를 60,360,925로 기재합니다. 이 206주는 2025-10-01제한 주식의 권리 행사를 통해 취득되었고 지급은 보상으로 기재됩니다. 제출 문서에는 또한 최근 3개월 동안 보고된 매도 4건이 총 7,470주$225,564.62의 금액으로 공시되어 있습니다. 서명자는 발행자에 관한 미공개 중요 정보가 없다고 진술합니다.

Résumé du formulaire TWST 144 : Cet avis fait état de ventes proposées et récentes d'actions ordinaires de Twist Bioscience par une personne identifiée comme Patrick Finn. Le déclarant propose de vendre 206 actions via Fidelity Brokerage avec une valeur marchande agrégée de 6 007,15 $ et indique le nombre d'actions en circulation de l'entreprise comme 60 360 925. Les 206 actions ont été acquises le 01/10/2025 via l'acquisition d'actions restreintes et le paiement est indiqué comme rémunération. Le dossier divulgue également quatre ventes rapportées au cours des trois mois précédents pour un total de 7 470 actions pour 225 564,62 $. Le signataire affirme ne détenir aucune information matérielle non divulguée sur l'émetteur.

TWST-Formular 144 Zusammenfassung: Diese Mitteilung meldet vorgesehene und jüngste Verkäufe von Twist Bioscience-Aktien durch eine Person namens Patrick Finn. Der Einreicher beabsichtigt, 206 Aktien über Fidelity Brokerage mit einem aggregierten Marktwert von $6.007,15 zu verkaufen und nennt die ausstehenden Aktien des Unternehmens mit 60.360.925. Die 206 Aktien wurden am 01.10.2025 durch Restricted Stock Vesting erworben, und die Zahlung wird als Vergütung aufgeführt. Die Einreichung gibt außerdem vier gemeldete Verkäufe im vorangegangenen Dreimonatszeitraum an, insgesamt 7.470 Aktien für $225.564,62. Der Unterzeichner erklärt, dass er über keine unangekündigten wesentlichen Informationen über den Emittenten verfügt.

ملخص نموذج TWST 144: يبين هذا الإشعار المبيعات المقترحة والمؤخّرة لأسهم الشركة Twist Bioscience العادية من قبل فرد محدد باسم Patrick Finn. يقترح المالك أن يبيع 206 أسهم عبر Fidelity Brokerage بقيمة سوقية إجمالية قدرها $6,007.15 ويذكر عدد الأسهم القائمة للشركة كـ 60,360,925. تم شراء الـ206 أسهم في 01/10/2025 من خلال تأهيل أسهم مقيدة ويحُول الدفع إلى تعويض. كما تكشف الوثيقة عن أربع مبيعات مُبلغ عنها في الأشهر الثلاثة السابقة بإجمالي 7,470 أسهم مقابل $225,564.62. يصر الموقع على أنه ليس لديه معلومات مادية لم تُكشف عن المصدر.

TWST 表格144摘要: 本通知报告了由被识别为 Patrick Finn 的个人提出和最近的 Twist Bioscience 普通股的销售。 披露人拟通过 Fidelity Brokerage 以 206 股 的数量进行出售,总市值为 $6,007.15,并将公司的在外流通股数列为 60,360,925。 这206股是在 2025-10-01 通过 限制性股票归属 获得,付款被列示为 报酬。 文件还披露在前3个月内的四笔报告销售,总计 7,470 股,金额为 $225,564.62。 签名人表示他对发行人没有未披露的重大信息。

Positive
  • None.
Negative
  • Insider sold 7,470 shares in the past three months for $225,564.62
  • Proposed sale of 206 shares (aggregate market value $6,007.15) to be executed on 10/02/2025

Riassunto del modulo TWST 144: Questo avviso riporta la vendita proposta e recente di azioni ordinarie di Twist Bioscience da parte di un individuo identificato come Patrick Finn. Il dichiarante propone di vendere 206 azioni tramite Fidelity Brokerage con un valore di mercato aggregato di $6.007,15 e indica il numero di azioni in circolazione della società come 60.360.925. Le 206 azioni sono state acquisite il 01/10/2025 tramite vesting di azioni limitate e il pagamento è indicato come compenso. La presentazione dichiara inoltre quattro vendite riportate nei tre mesi precedenti per un totale di 7.470 azioni per $225.564,62. Il firmatario dichiara di non possedere informazioni materiali non divulgate sull'emittente.

Resumen del Formulario 144 de TWST: Este aviso informa ventas propuestas y recientes de acciones ordinarias de Twist Bioscience por una persona identificada como Patrick Finn. El presentante propone vender 206 acciones a través de Fidelity Brokerage con un valor de mercado agregado de $6,007.15 y señala el número de acciones en circulación de la empresa como 60,360,925. Las 206 acciones se adquirieron el 01/10/2025 mediante vesting de acciones restringidas y el pago se indica como compensación. La presentación también divulga cuatro ventas reportadas en los tres meses anteriores por un total de 7,470 acciones por $225,564.62. El firmante declara no poseer información material no revelada sobre el emisor.

TWST Form 144 요약: 이 공지는 Patrick Finn으로 식별된 개인이 Twist Bioscience의 보통주를 제안 및 최근에 매각한 내용을 보고합니다. 제출자는 Fidelity Brokerage를 통해 206주를 매도할 계획이며 합산 시장가치 $6,007.15를 제시하고 회사의 발행주식 수를 60,360,925로 기재합니다. 이 206주는 2025-10-01제한 주식의 권리 행사를 통해 취득되었고 지급은 보상으로 기재됩니다. 제출 문서에는 또한 최근 3개월 동안 보고된 매도 4건이 총 7,470주$225,564.62의 금액으로 공시되어 있습니다. 서명자는 발행자에 관한 미공개 중요 정보가 없다고 진술합니다.

Résumé du formulaire TWST 144 : Cet avis fait état de ventes proposées et récentes d'actions ordinaires de Twist Bioscience par une personne identifiée comme Patrick Finn. Le déclarant propose de vendre 206 actions via Fidelity Brokerage avec une valeur marchande agrégée de 6 007,15 $ et indique le nombre d'actions en circulation de l'entreprise comme 60 360 925. Les 206 actions ont été acquises le 01/10/2025 via l'acquisition d'actions restreintes et le paiement est indiqué comme rémunération. Le dossier divulgue également quatre ventes rapportées au cours des trois mois précédents pour un total de 7 470 actions pour 225 564,62 $. Le signataire affirme ne détenir aucune information matérielle non divulguée sur l'émetteur.

TWST-Formular 144 Zusammenfassung: Diese Mitteilung meldet vorgesehene und jüngste Verkäufe von Twist Bioscience-Aktien durch eine Person namens Patrick Finn. Der Einreicher beabsichtigt, 206 Aktien über Fidelity Brokerage mit einem aggregierten Marktwert von $6.007,15 zu verkaufen und nennt die ausstehenden Aktien des Unternehmens mit 60.360.925. Die 206 Aktien wurden am 01.10.2025 durch Restricted Stock Vesting erworben, und die Zahlung wird als Vergütung aufgeführt. Die Einreichung gibt außerdem vier gemeldete Verkäufe im vorangegangenen Dreimonatszeitraum an, insgesamt 7.470 Aktien für $225.564,62. Der Unterzeichner erklärt, dass er über keine unangekündigten wesentlichen Informationen über den Emittenten verfügt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

Who is the seller named in the TWST Form 144?

The filing lists Patrick Finn as the person for whose account the securities were or will be sold.

How many shares does the Form 144 propose to sell for TWST?

The notice proposes the sale of 206 shares of common stock with an aggregate market value of $6,007.15.

What recent insider sales are disclosed in this TWST filing?

Four sales in the prior three months totaling 7,470 shares for $225,564.62 (dates: 07/02/2025, 07/23/2025, 08/04/2025, 08/21/2025).

How were the 206 shares being offered for sale acquired?

They were acquired on 10/01/2025 via restricted stock vesting, with consideration listed as compensation.

What outstanding share count does the filing report for TWST?

The filing lists 60,360,925 shares outstanding.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.85B
59.19M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO